塞图西马布装饰的氧化还原敏感的D-alpha-tocopheryl-聚乙烯基醇-1000-succinate基纳米颗粒用于cabazitaxel输送:配方,肺向和增强的抗癌作用
Aseem Setia1, Pooja Kumari2, Vikas1
1Department of Pharmaceutical Engineering and Technology, IIT BHU, Varanasi 221005, UP, India.
International journal of pharmaceutics
|February 6, 2024
概括
这项研究开发了载有cabazitaxel的向纳米颗粒,用于肺癌治疗. 这种新型的 cetuximab 装饰的纳米颗粒显著增强了药物递送和细胞毒性,显示出 EGFR 向肺瘤治疗的前景.
科学领域:
- 纳米医学是一种纳米医学.
- 药物输送系统 药物输送系统
- 癌症治疗 癌症治疗
背景情况:
- 肺癌仍然是全球癌症相关死亡的主要原因之一.
- 有针对性的药物输送系统对于提高治疗疗效和减少副作用至关重要.
- 皮表皮生长因子受体 (EGFR) 是肺癌治疗的关键标.
研究的目的:
- 用于制造装饰着 cetuximab (CTX) 的,对氧化回归敏感的cabazitaxel (CBZ) 装载的 D-alpha-tocopheryl-polyethyleneglycol-1000-succinate (TPGS-SS) 纳米粒子 (NP).
- 评估这些针对EGFR向肺瘤治疗的向NP的疗效.
- 评估开发的NP的体外药物释放,细胞毒性和细胞吸收.
主要方法:
- 用透析袋扩散方法制备纳米颗粒.
- 特性包括粒子大小,多分散性,表面电荷,表面形态和捕获效率.
- 试验室研究包括药物释放,细胞毒性测定 (IC50测定) 和A549细胞中的细胞吸收调查.
主要成果:
- 开发的NP范围从145.6到308.06纳米,表面电荷为-15到-23mV.
- 与临床cabazitaxel注射相比,目标CTX-TPGS-SS-CBZ-NP显示细胞毒性显著增加4.37倍.
- 在体外细胞吸收研究显示,CTX-TPGS-SS-NP在A549细胞中的积累明显高于非向配方.
结论:
- 制造的CTX装饰,氧化回归敏感TPGS-SS纳米颗粒显示增强的细胞毒性和细胞吸收用于肺癌治疗.
- 这些向纳米颗粒代表了EGFR向肺瘤治疗的有前途平台.
- 需要进一步的体内研究来验证这些新型纳米载体的治疗潜力.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


